Loading clinical trials...
Loading clinical trials...
This trial is conducted in Asia, Europe, Japan, Oceania, North America and South America. The aim of the trial is to investigate the safety and efficacy of turoctocog alfa (N8) in Haemophilia A patie...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT06716814 · Haemophilia A (Moderate or Severe)
NCT06352216 · Haemophilia A, Synovitis, and more
NCT06285071 · Haemophilia A, Haemophilia B
NCT06831734 · Haemophilia A, Haemophilia B
NCT06752850 · Haemophilia A (Moderate or Severe), Hemophilia, Classic, and more
Novo Nordisk Investigational Site
Phoenix, Arizona
Novo Nordisk Investigational Site
Long Beach, California
Novo Nordisk Investigational Site
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions